The diffusibility of bacampicillin, ampicillin, cephalothin, and cephapirin into human interstitial fluid was investigated by using crossover studies. We compared bacampicillin with ampicillin and found that bacampicillin was better absorbed after oral administration. Blood, interstitial fluid, and urine levels were consistently higher in volunteers who received bacampicillin. We compared cephalothin with cephapirin and found that blood and interstitial fluid levels were comparable throughout the study. Bacampicillin versus ampiciflin. Six volunteers were given 1,600 mg of bacampicillin (equivalent to 1,112 mg of ampicillin), and six were given 2,000 mg of ampicillin. Both drugs were given by mouth after an 8-h fast. The study was repeated after 1 week, and the volunteers received the drug that they had not received previously.
The diffusibility of bacampicillin, ampicillin, cephalothin, and cephapirin into human interstitial fluid was investigated by using crossover studies. We compared bacampicillin with ampicillin and found that bacampicillin was better absorbed after oral administration. Blood, interstitial fluid, and urine levels were consistently higher in volunteers who received bacampicillin. We compared cephalothin with cephapirin and found that blood and interstitial fluid levels were comparable throughout the study.
Two crossover studies were designed to compare the diffusibilities of bacampicillin and ampicillin, and cephalothin and cephapirin by using a skin window technique. Bacampicillin, a new semisynthetic penicillin, is a hydrochloride of the 1-ethoxycarbonyloxyethyl ester of ampicilin (4) Bacampicillin versus ampiciflin. Six volunteers were given 1,600 mg of bacampicillin (equivalent to 1,112 mg of ampicillin), and six were given 2,000 mg of ampicillin. Both drugs were given by mouth after an 8-h fast. The study was repeated after 1 week, and the volunteers received the drug that they had not received previously.
Cephalothin (Keflin neutral) versus cephapirin (Cefadyl). Six volunteers were given 1 g of one drug over a 30-min period by intravenous infusion, and six were given 1 g of the other drug. The study was repeated after 3 weeks. The volunteers received the drugs which they had not received previously.
Blood samples. Venous blood was obtained before and 0.5, 1, 1.5, 2, 3, 4, and 5 h after administration of bacampicillin or ampicillin. The serum was separated after 45 min at 240C and immediately frozen. Venous blood was obtained before and 0.5, 1, 2, 3, and 4 h after the start of intravenous infusion of cephalothin or cephapirin. Blood was drawn into a heparinized tube to reduce deacetylation of the cephalosporins, and the plasma was separated and immediately frozen.
Interstitial fluid samples. The technique of obtaining interstitial fluid by using a skin window chamber has been described previously (13).
Urine sampling. Urine samples from six volunteers receiving bacampicillin and six receiving ampicillin were collected at 2, 4, and 5 h after antibiotic administration.
Assay of antibiotics. Antibiotics were assayed by the agar well technique described by Bennett et al. (2) , using a Bacillus subtilis spore suspension (Difco Laboratories, Detroit, Mich.) as the test organism. Pooled human plasma was used as the diluent for the standards of the serum and plasma antibiotic assay. Phosphate-buffered saline (pH 6) was used to dilute the standards for the skin window fluid assay.
RESULTS
Bacampicillin versus ampicillin. The dose of bacampicillin administered was approximately half that of ampicillin, yet the serum antibiotic concentrations after the administration of bacampicillin consistently were higher during the first 3 h (Table 1) . Similarly, the interstitial fluid levels of bacampicillin were also consistently higher. The serum and skin window fluid ratios were almost identical throughout the 5 h of the study.
At the end of 5 h, volunteers who received ampicillin excreted in the urine an average of 492 mg of ampicillin, which is equivalent to 25% of the ingested dose. Volunteers who received bacampicillin excreted an average of 701 mg of ampicillin, which is equivalent to 63% of the ingested dose.
Cephalothin versus cephapirm. The mean plasma and skin window fluid levels of cephapirin after 1, 2, and 3 h were slightly but not VOL. 15, 1979 ANTIBIOTIC LE significantly higher than those of cephalothin ( Table 2 ). The plasma skin window fluid ratios were slightly higher than those of cephalothin. Of the 12 volunteers who received caphalothin, 3 complained of a burning sensation at the site of infusion when the cephalothin was started. This was not observed in the volunteers who received cephapirin. None of the volunteers knew which antibiotic they were receiving.
DISCUSSION
This study confirned the findings of others (3, 10) that bacampicillin given orally is better absorbed t14an ampicillin, as demonstrated by higher blood and urine levels. By using a pharmacokinetic model, a peak "tissue" concentra-tion is observed after bacampicillin administration at 2 h and after ampicillin administration at 3 h (10). In our present study, a peak coincentration after oral bacampicillin administration was obtained at 1.5 h and was maintained until the third hour, whereas those who received oral ampicillin had a peak concentration at 3 h. The skin window serum ratio found in this study was comparable to that found in the previous studies on ampicillin (11) .
The plasma levels after the administration of jephalothin and cephapirin were comparable throughout the 4-h study. The levels and ratios of cephalothin were slightly but not significantly lower than in our previous study (12) . The slightly higher cephapirin levels in the intersti- tial fluid may have been due to the lower protein binding of cephapirin (44 to 50%) (8) . Cephalothin is 65% protein bound (8) . Venous irritation after cephalothin administration was reported by three volunteers. This confirmed the observation of a lower frequency of phlebitis after cephapirin administration (6, 8) . However, Carrizosa et al., in a double-blind study, showed no difference in phlebitis potential between the two drugs (5).
